US20030022863A1 - Antiadhesive carbohydrates - Google Patents

Antiadhesive carbohydrates Download PDF

Info

Publication number: US20030022863A1
Authority: US; United States
Prior art keywords: carbohydrates; antiadhesive; carbohydrate; uronic acid; pharmaceutical
Prior art date: 2000-02-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

US10/182,739

Other languages

English (en)

Inventor

Bernd Stahl

Gunther Boehm

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nutricia NV

Original Assignee

Nutricia NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-16

Filing date

2001-02-16

Publication date

2003-01-30

2001-02-16 Application filed by Nutricia NV filed Critical Nutricia NV

2002-08-14 Assigned to N.V. NUTRICIA reassignment N.V. NUTRICIA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOEHM, GUNTHER, STAHL, BERND

2003-01-30 Publication of US20030022863A1 publication Critical patent/US20030022863A1/en

2005-12-22 Priority to US11/313,674 priority Critical patent/US7759324B2/en

2006-08-29 Priority to US11/511,500 priority patent/US7919479B2/en

2011-03-02 Priority to US13/038,741 priority patent/US20110152168A1/en

Status Abandoned legal-status Critical Current

Links

150000001720 carbohydrates Chemical class 0.000 title claims abstract description 234
235000014633 carbohydrates Nutrition 0.000 title claims abstract description 206
230000000181 anti-adherent effect Effects 0.000 title claims description 98
239000002253 acid Substances 0.000 claims abstract description 69
238000002360 preparation method Methods 0.000 claims abstract description 31
235000005911 diet Nutrition 0.000 claims abstract description 16
230000000378 dietary effect Effects 0.000 claims abstract description 16
239000000126 substance Substances 0.000 claims abstract description 14
241000124008 Mammalia Species 0.000 claims abstract description 9
230000001717 pathogenic effect Effects 0.000 claims abstract description 5
230000000903 blocking effect Effects 0.000 claims abstract description 4
239000000203 mixture Substances 0.000 claims description 27
235000013406 prebiotics Nutrition 0.000 claims description 24
238000006116 polymerization reaction Methods 0.000 claims description 13
244000052769 pathogen Species 0.000 claims description 12
210000001035 gastrointestinal tract Anatomy 0.000 claims description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
230000007935 neutral effect Effects 0.000 claims description 7
239000000825 pharmaceutical preparation Substances 0.000 claims description 7
239000008280 blood Substances 0.000 claims description 5
210000004369 blood Anatomy 0.000 claims description 5
150000004676 glycans Chemical class 0.000 claims description 5
229920001542 oligosaccharide Polymers 0.000 claims description 5
229920001282 polysaccharide Polymers 0.000 claims description 5
239000005017 polysaccharide Substances 0.000 claims description 5
208000015181 infectious disease Diseases 0.000 claims description 4
210000002429 large intestine Anatomy 0.000 claims description 4
150000002482 oligosaccharides Chemical class 0.000 claims description 4
230000000241 respiratory effect Effects 0.000 claims description 4
239000000969 carrier Substances 0.000 claims description 3
150000001768 cations Chemical class 0.000 claims description 3
230000032050 esterification Effects 0.000 claims description 3
238000005886 esterification reaction Methods 0.000 claims description 3
229910001385 heavy metal Inorganic materials 0.000 claims description 3
239000003053 toxin Substances 0.000 claims description 3
231100000765 toxin Toxicity 0.000 claims description 3
108700012359 toxins Proteins 0.000 claims description 3
PZUPAGRIHCRVKN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-5-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound OCC1OC(O)C(O)C(O)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(COC4C(C(O)C(O)CO4)O)O3)O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(COC2C(C(O)C(O)CO2)O)O1 PZUPAGRIHCRVKN-UHFFFAOYSA-N 0.000 claims description 2
239000002671 adjuvant Substances 0.000 claims description 2
239000003085 diluting agent Substances 0.000 claims description 2
235000013619 trace mineral Nutrition 0.000 claims description 2
239000011573 trace mineral Substances 0.000 claims description 2
235000013343 vitamin Nutrition 0.000 claims description 2
239000011782 vitamin Substances 0.000 claims description 2
229940088594 vitamin Drugs 0.000 claims description 2
229930003231 vitamin Natural products 0.000 claims description 2
239000000306 component Substances 0.000 claims 9
235000012041 food component Nutrition 0.000 claims 2
239000005428 food component Substances 0.000 claims 1
239000005417 food ingredient Substances 0.000 claims 1
238000003776 cleavage reaction Methods 0.000 description 17
230000007017 scission Effects 0.000 description 17
210000004027 cell Anatomy 0.000 description 16
229920001277 pectin Polymers 0.000 description 14
239000001814 pectin Substances 0.000 description 14
235000010987 pectin Nutrition 0.000 description 14
230000002255 enzymatic effect Effects 0.000 description 7
239000000243 solution Substances 0.000 description 7
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 6
230000001747 exhibiting effect Effects 0.000 description 6
239000000047 product Substances 0.000 description 6
241000894007 species Species 0.000 description 6
239000000872 buffer Substances 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
241000196324 Embryophyta Species 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
235000013305 food Nutrition 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
229920001202 Inulin Polymers 0.000 description 3
108010029182 Pectin lyase Proteins 0.000 description 3
229920000615 alginic acid Polymers 0.000 description 3
235000010443 alginic acid Nutrition 0.000 description 3
-1 barium salt) Chemical class 0.000 description 3
230000037396 body weight Effects 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
235000021255 galacto-oligosaccharides Nutrition 0.000 description 3
150000003271 galactooligosaccharides Chemical class 0.000 description 3
230000000968 intestinal effect Effects 0.000 description 3
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
229940029339 inulin Drugs 0.000 description 3
239000003446 ligand Substances 0.000 description 3
230000011987 methylation Effects 0.000 description 3
238000007069 methylation reaction Methods 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
229920000189 Arabinogalactan Polymers 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
229920000926 Galactomannan Polymers 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
108090000856 Lyases Proteins 0.000 description 2
102000004317 Lyases Human genes 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
229940072056 alginate Drugs 0.000 description 2
235000019312 arabinogalactan Nutrition 0.000 description 2
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
229940097043 glucuronic acid Drugs 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
230000003993 interaction Effects 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000012528 membrane Substances 0.000 description 2
238000000034 method Methods 0.000 description 2
150000002772 monosaccharides Chemical class 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
210000000813 small intestine Anatomy 0.000 description 2
239000012064 sodium phosphate buffer Substances 0.000 description 2
239000007858 starting material Substances 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
IAJILQKETJEXLJ-STGXQOJASA-N (2s,3s,4r,5s)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-STGXQOJASA-N 0.000 description 1
AQFATCCHOXBYNK-UHFFFAOYSA-N 2-piperidin-1-ium-1-ylethyl 1-cyclohexylcyclohexane-1-carboxylate;chloride Chemical compound [Cl-].C1CCCCC1(C1CCCCC1)C(=O)OCC[NH+]1CCCCC1 AQFATCCHOXBYNK-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
235000016068 Berberis vulgaris Nutrition 0.000 description 1
241000335053 Beta vulgaris Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229920002567 Chondroitin Polymers 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
VQUZNVATTCZTQO-UHFFFAOYSA-N D-xyluronic acid Natural products O=CC(O)C(O)C(O)C(O)=O VQUZNVATTCZTQO-UHFFFAOYSA-N 0.000 description 1
244000000626 Daucus carota Species 0.000 description 1
235000002767 Daucus carota Nutrition 0.000 description 1
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
241000233866 Fungi Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
229920002971 Heparan sulfate Polymers 0.000 description 1
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
239000005913 Maltodextrin Substances 0.000 description 1
244000141359 Malus pumila Species 0.000 description 1
VQUZNVATTCZTQO-HZLVTQRSSA-N O=C[C@H](O)[C@H](O)[C@H](O)C(O)=O Chemical compound O=C[C@H](O)[C@H](O)[C@H](O)C(O)=O VQUZNVATTCZTQO-HZLVTQRSSA-N 0.000 description 1
229920002230 Pectic acid Polymers 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
244000269722 Thea sinensis Species 0.000 description 1
241000700605 Viruses Species 0.000 description 1
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
235000021016 apples Nutrition 0.000 description 1
239000006286 aqueous extract Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
159000000009 barium salts Chemical class 0.000 description 1
AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
238000007068 beta-elimination reaction Methods 0.000 description 1
230000027455 binding Effects 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
238000005251 capillar electrophoresis Methods 0.000 description 1
235000021218 carrot soup Nutrition 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
235000020971 citrus fruits Nutrition 0.000 description 1
235000020197 coconut milk Nutrition 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
235000013681 dietary sucrose Nutrition 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
229940079919 digestives enzyme preparation Drugs 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
239000003925 fat Substances 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
239000012467 final product Substances 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
235000020256 human milk Nutrition 0.000 description 1
210000004251 human milk Anatomy 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
IAJILQKETJEXLJ-LECHCGJUSA-N iduronic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-LECHCGJUSA-N 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
229960001375 lactose Drugs 0.000 description 1
239000008101 lactose Substances 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
229940035034 maltodextrin Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000004702 methyl esters Chemical class 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
239000000178 monomer Chemical group 0.000 description 1
230000000050 nutritive effect Effects 0.000 description 1
238000002103 osmometry Methods 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
244000045947 parasite Species 0.000 description 1
108010087558 pectate lyase Proteins 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
108010004131 poly(beta-D-mannuronate) lyase Proteins 0.000 description 1
230000008569 process Effects 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
210000002345 respiratory system Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000007974 sodium acetate buffer Substances 0.000 description 1
229940032147 starch Drugs 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
229960004793 sucrose Drugs 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
230000001018 virulence Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Definitions

the prebiotic carbohydrates/saccharides, which constitute the carbohydrate component A have another structure than the prebiotic carbohydrates/saccharides, which constitute the carbohydrate component B. Further preferred are at least 80 wt-% of the prebiotic carbohydrates/saccharides of the carbohydrate component A and B, namely those which favor lactic acid bacteria and/or are bifidogenous.
the weight percentage of the carbohydrate component A is in this case preferably larger than the weight percentage of the carbohydrate component B.

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Nutrition Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Dispersion Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Otolaryngology (AREA)
Toxicology (AREA)
Virology (AREA)
Diabetes (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Adhesives Or Adhesive Processes (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Dental Preparations (AREA)
Steroid Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

US10/182,739 2000-02-16 2001-02-16 Antiadhesive carbohydrates Abandoned US20030022863A1 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
US11/313,674 US7759324B2 (en)	2000-02-16	2005-12-22	Antiadhesive carbohydrates
US11/511,500 US7919479B2 (en)	2000-02-16	2006-08-29	Antiadhesive carbohydrates
US13/038,741 US20110152168A1 (en)	2000-02-16	2011-03-02	Antiadhesive carbohydrates

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10006989.4		2000-02-16
DE10006989A DE10006989A1 (de)	2000-02-16	2000-02-16	Antiadhäsive Kohlenhydratmischung

Related Child Applications (2)

Application Number	Title	Priority Date	Filing Date
US11/313,674 Continuation US7759324B2 (en)	2000-02-16	2005-12-22	Antiadhesive carbohydrates
US11/511,500 Continuation US7919479B2 (en)	2000-02-16	2006-08-29	Antiadhesive carbohydrates

Publications (1)

Publication Number	Publication Date
US20030022863A1 true US20030022863A1 (en)	2003-01-30

Family

ID=7631150

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
US10/182,739 Abandoned US20030022863A1 (en)	2000-02-16	2001-02-16	Antiadhesive carbohydrates
US11/313,674 Expired - Fee Related US7759324B2 (en)	2000-02-16	2005-12-22	Antiadhesive carbohydrates
US11/511,500 Expired - Fee Related US7919479B2 (en)	2000-02-16	2006-08-29	Antiadhesive carbohydrates
US13/038,741 Abandoned US20110152168A1 (en)	2000-02-16	2011-03-02	Antiadhesive carbohydrates

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
US11/313,674 Expired - Fee Related US7759324B2 (en)	2000-02-16	2005-12-22	Antiadhesive carbohydrates
US11/511,500 Expired - Fee Related US7919479B2 (en)	2000-02-16	2006-08-29	Antiadhesive carbohydrates
US13/038,741 Abandoned US20110152168A1 (en)	2000-02-16	2011-03-02	Antiadhesive carbohydrates

Country Status (26)

Country	Link
US (4)	US20030022863A1 (fr)
EP (3)	EP2298325A1 (fr)
JP (1)	JP4965043B2 (fr)
CN (2)	CN101057853B (fr)
AT (1)	ATE517628T1 (fr)
AU (2)	AU2001246441B2 (fr)
BR (1)	BR0108354B1 (fr)
CA (2)	CA2400244C (fr)
CY (1)	CY1111968T1 (fr)
CZ (1)	CZ20022702A3 (fr)
DE (1)	DE10006989A1 (fr)
DK (1)	DK1267891T3 (fr)
ES (1)	ES2370478T3 (fr)
HK (1)	HK1053986A1 (fr)
HU (1)	HUP0300409A3 (fr)
IL (1)	IL151274A (fr)
MX (1)	MXPA02007970A (fr)
NO (2)	NO331735B1 (fr)
NZ (1)	NZ520642A (fr)
PL (1)	PL204585B1 (fr)
PT (1)	PT1267891E (fr)
RU (1)	RU2267324C2 (fr)
SK (1)	SK288087B6 (fr)
TR (1)	TR200202008T2 (fr)
WO (1)	WO2001060378A2 (fr)
ZA (1)	ZA200206177B (fr)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005039597A3 (fr) *	2003-10-24	2005-07-14	Nutricia Nv	Oligosaccharides immunomodulatrices
EP1629850A1 (fr)	2004-08-24	2006-03-01	Nutricia N.V.	Composition nutritive comprenant des oligosaccharides indigestes
US20060110516A1 (en) *	2002-08-30	2006-05-25	Holtus Maria F	Foaming ingredient and products containing the ingredient
EP1714562A1 (fr) *	2005-04-22	2006-10-25	N.V. Nutricia	Procédé de séchage d'oligosaccahrides d'acide uronique
GB2430881A (en) *	2005-10-06	2007-04-11	Ntnu Technology Transfer As	Use of an oligoelectrolyte polyol to treat mucosal hyperviscosity
WO2007046697A1 (fr) *	2005-10-21	2007-04-26	N.V. Nutricia	Methode pour traiter et/ou pour prevenir des infections chez des bebes venus au monde par cesarienne
WO2007067053A1 (fr) *	2005-12-06	2007-06-14	N.V. Nutricia	Préparation contenant des oligosaccharides pour le traitement prophylactique/thérapeutique d'infections
US20080064656A1 (en) *	2004-06-22	2008-03-13	N,V, Nutricia	Improvement of intestinal barrier integrity
US20080171720A1 (en) *	2005-04-21	2008-07-17	N.V. Nutricia	Nutritional Supplement For Hiv Patients
US20080207559A1 (en) *	1998-08-11	2008-08-28	N.V. Nutricia	Carbohydrates mixture
US20090082249A1 (en) *	2005-04-21	2009-03-26	N.V. Nutricia	Nutritional supplement for a category of hiv patients
US20100069320A1 (en) *	2004-05-17	2010-03-18	N.V. Nutricia	Synergism of gos and polyfructose
US20100152122A1 (en) *	2007-04-12	2010-06-17	Ntnu Technology Transfer As	Oligo-guluronate and galacturonate compositions
US20100167982A1 (en) *	2004-06-22	2010-07-01	N.V. Nutricia	Barrier integrity in hiv patients
US20100305062A1 (en) *	2007-11-27	2010-12-02	Algipharma Ipr As	Use of alginate oligomers in combating biofilms
US20110008485A1 (en) *	2007-12-05	2011-01-13	N.V. Nutricia	Protein-dense micellar casein-based liquid enteral nutritional composition
US20110021421A1 (en) *	2007-12-05	2011-01-27	N.V. Nutricia	Liquid enteral nutritional composition with a low specific protein volume
US20110038982A1 (en) *	2007-12-05	2011-02-17	N.V. Nutricia	High energy liquid enteral nutritional composition
US20110046048A1 (en) *	2008-03-12	2011-02-24	N.V. Nutricia	High protein liquid enteral nutritional composition
US20110077189A1 (en) *	2008-02-01	2011-03-31	N.V. Nutricia	Composition for stimulating natural killer cell activity
US20110150851A1 (en) *	2008-06-30	2011-06-23	N.V. Nutricia	Nutritional composition for infants delivered via caesarean section
US20110236500A1 (en) *	2005-04-21	2011-09-29	N.V. Nutricia	Nutritional supplement with colostrum and epa or dha or gla
US8529890B2 (en)	2009-03-23	2013-09-10	Ntnu Technology Transfer As	Composition for the administration of polymeric drugs
US8815831B2 (en)	2009-06-03	2014-08-26	Algipharma As	Treatment of Acinetobacter with alginate oligomers and antibiotics
US8987215B2 (en)	2009-03-23	2015-03-24	Ntnu Technology Transfer As	Composition for use in gene therapy

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10057976B4 (de)	2000-11-22	2005-02-03	Südzucker AG Mannheim/Ochsenfurt	Verfahren zur Herstellung von Pektinhydrolyseprodukten
FR2831819B1 (fr) *	2001-11-08	2004-09-03	Rocher Yves Biolog Vegetale	Utilisation d'oligosaccharides dans des compositions cosmetiques ou dermatologiques pour stimuler l'adhesion de keratinocytes sur les proteines majeures de la jonction dermo-epidermique
EP1634599A1 (fr)	2004-08-20	2006-03-15	N.V. Nutricia	Aliment infantile à activité immunostimulatrice
EP1745705A1 (fr) *	2005-07-20	2007-01-24	N.V. Nutricia	Procédé de préparation d' oligosaccharides d' acide uronique par extrusion
WO2009075564A1 (fr)	2007-12-10	2009-06-18	N.V. Nutricia	Mélange de fibres pédiatriques
RU2367686C1 (ru) *	2008-03-31	2009-09-20	Ирина Викторовна Анохина	Способ получения антиадгезивного компонента на основе лектинсвязывающих структур
EP2130440A1 (fr) *	2008-06-06	2009-12-09	N.V. Nutricia	Inhibition de croissance E. Sakazakii
WO2010002242A1 (fr)	2008-07-02	2010-01-07	N.V. Nutricia	Composition nutritionnelle pour améliorer la fonction musculaire et l'activité quotidienne
WO2010140877A1 (fr)	2009-06-05	2010-12-09	N.V. Nutricia	Composition nutritionnelle entérale liquide avec une faible teneur en ion métallique monovalent
WO2011078654A1 (fr)	2009-12-24	2011-06-30	N.V. Nutricia	Composition nutritionnelle hypocalorique riche en protéines destinée à la stimulation de la synthèse des protéines musculaires
WO2011112075A1 (fr)	2010-03-11	2011-09-15	N.V. Nutricia	Régulation de la texture de compositions nutritionnelles à forte teneur en protéines contenant de la caséine micellaire
WO2012005568A1 (fr)	2010-07-07	2012-01-12	N.V. Nutricia	Composition nutritive de stimulation de synthèse de protéines musculaires
RU2441024C1 (ru) *	2010-07-21	2012-01-27	Учреждение Российской академии наук Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения РАН	Способ получения низкомолекулярного пектина
RU2441025C1 (ru) *	2010-07-21	2012-01-27	Учреждение Российской академии наук Институт биологии моря им.А.В.Жирмунского Дальневосточного отделения РАН	Способ получения низкомолекулярного пектина
WO2013012313A1 (fr)	2011-07-18	2013-01-24	N.V. Nutricia	Utilisation d'un nucléotide pour améliorer la stabilité thermique d'une composition de caséine micellaire aqueuse
RU2586150C2 (ru)	2012-02-10	2016-06-10	Н.В. Нутриция	Добавка для матери, предназначенная для укрепления иммунной системы ребенка
WO2013117234A1 (fr)	2012-02-10	2013-08-15	N.V. Nutricia	Composition maternelle visant à renforcer le système immunitaire
WO2013129912A1 (fr)	2012-02-28	2013-09-06	N.V. Nutricia	Composition nutritionnelle liquide énergétique ayant des propriétés organoleptiques améliorées
US9314494B2 (en)	2012-05-25	2016-04-19	The United States Of America, As Represented By The Secretary Of Agriculture	Cranberry xyloglucan oligosaccharide composition
CN105451578A (zh)	2013-06-10	2016-03-30	N·V·努特里奇亚	超重或肥胖成年人在体重减轻项目期间的肌肉保持
MA41020A (fr)	2014-11-25	2017-10-03	Evelo Biosciences Inc	Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
JP6895961B2 (ja)	2015-11-03	2021-06-30	ザブリガムアンドウィメンズホスピタルインコーポレイテッドＴｈｅＢｒｉｇｈａｍａｎｄＷｏｍｅｎ’ｓＨｏｓｐｉｔａｌ，Ｉｎｃ．	食物アレルギーの処置および／または防止のための治療用微生物叢
WO2022036623A1 (fr) *	2020-08-20	2022-02-24	中国科学院微电子研究所	Sot-mram à renversement de spin orienté champ magnétique non externe et réseau

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4619831A (en) *	1984-06-04	1986-10-28	Warner-Lambert Company	Dietary fiber composition and process of manufacture
US5952308A (en) *	1991-07-29	1999-09-14	Pola Chemical Industries Inc.	Mineral absorption promoting agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3046414A1 (de) *	1980-12-10	1982-07-29	Thiele Forschung Diaetetische	"nahrungs- oder heilmittel"
DE4330773A1 (de) *	1993-09-10	1995-03-16	Laevosan Gmbh & Co Kg	Blockierung der Anlagerung von Keimen an menschliche Zellen
DE19503423A1 (de) *	1995-02-03	1996-08-08	Beiersdorf Ag	Antiadhäsive Wirkstoffe
WO1997033593A1 (fr) *	1996-03-15	1997-09-18	Takara Shuzo Co., Ltd.	Produit obtenu par traitement thermique d'acide uronique, et aliments, boissons ou medicaments contenant ce produit
KR100450097B1 (ko) *	1996-08-09	2004-09-30	마나테크 인코포레이티드	식이 보조제 용도의 식물 탄수화물 조성물
JPH10226701A (ja) *	1997-02-14	1998-08-25	Yoko Takenaka	オリゴガラクツロン酸含有抗菌組成物及びその製造方法
WO1999064022A1 (fr) *	1998-06-10	1999-12-16	Crum Albert B	Complement nutritionnel prophylactique et therapeutique destine a la creation/au maintien d'une microflore intestinale protectrice de la sante et au renforcement du systeme immunitaire
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung

2000
- 2000-02-16 DE DE10006989A patent/DE10006989A1/de not_active Withdrawn
2001
- 2001-02-16 BR BRPI0108354-6A patent/BR0108354B1/pt not_active IP Right Cessation
- 2001-02-16 CN CN200710100849.6A patent/CN101057853B/zh not_active Expired - Fee Related
- 2001-02-16 CA CA2400244A patent/CA2400244C/fr not_active Expired - Fee Related
- 2001-02-16 AT AT01919291T patent/ATE517628T1/de active
- 2001-02-16 PL PL363272A patent/PL204585B1/pl unknown
- 2001-02-16 SK SK1168-2002A patent/SK288087B6/sk not_active IP Right Cessation
- 2001-02-16 US US10/182,739 patent/US20030022863A1/en not_active Abandoned
- 2001-02-16 HK HK03106357.1A patent/HK1053986A1/zh unknown
- 2001-02-16 WO PCT/EP2001/001753 patent/WO2001060378A2/fr not_active Ceased
- 2001-02-16 EP EP10181824A patent/EP2298325A1/fr not_active Withdrawn
- 2001-02-16 CA CA2765218A patent/CA2765218A1/fr not_active Abandoned
- 2001-02-16 EP EP01919291A patent/EP1267891B1/fr not_active Expired - Lifetime
- 2001-02-16 HU HU0300409A patent/HUP0300409A3/hu not_active IP Right Cessation
- 2001-02-16 EP EP10183673A patent/EP2305270A1/fr not_active Withdrawn
- 2001-02-16 TR TR2002/02008T patent/TR200202008T2/xx unknown
- 2001-02-16 CN CN01805223A patent/CN1404395A/zh active Pending
- 2001-02-16 MX MXPA02007970A patent/MXPA02007970A/es active IP Right Grant
- 2001-02-16 PT PT01919291T patent/PT1267891E/pt unknown
- 2001-02-16 DK DK01919291.3T patent/DK1267891T3/da active
- 2001-02-16 CZ CZ20022702A patent/CZ20022702A3/cs unknown
- 2001-02-16 NZ NZ520642A patent/NZ520642A/en not_active IP Right Cessation
- 2001-02-16 JP JP2001559474A patent/JP4965043B2/ja not_active Expired - Fee Related
- 2001-02-16 AU AU2001246441A patent/AU2001246441B2/en not_active Ceased
- 2001-02-16 ES ES01919291T patent/ES2370478T3/es not_active Expired - Lifetime
- 2001-02-16 AU AU4644101A patent/AU4644101A/xx active Pending
- 2001-02-16 RU RU2002124589/15A patent/RU2267324C2/ru not_active IP Right Cessation
2002
- 2002-08-02 ZA ZA200206177A patent/ZA200206177B/en unknown
- 2002-08-14 NO NO20023846A patent/NO331735B1/no not_active IP Right Cessation
- 2002-08-15 IL IL151274A patent/IL151274A/en not_active IP Right Cessation
2005
- 2005-12-22 US US11/313,674 patent/US7759324B2/en not_active Expired - Fee Related
2006
- 2006-08-29 US US11/511,500 patent/US7919479B2/en not_active Expired - Fee Related
2011
- 2011-03-02 US US13/038,741 patent/US20110152168A1/en not_active Abandoned
- 2011-07-14 NO NO20111024A patent/NO20111024L/no not_active Application Discontinuation
- 2011-10-27 CY CY20111101027T patent/CY1111968T1/el unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4619831A (en) *	1984-06-04	1986-10-28	Warner-Lambert Company	Dietary fiber composition and process of manufacture
US5952308A (en) *	1991-07-29	1999-09-14	Pola Chemical Industries Inc.	Mineral absorption promoting agent

Cited By (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080207559A1 (en) *	1998-08-11	2008-08-28	N.V. Nutricia	Carbohydrates mixture
US9763466B2 (en)	1998-08-11	2017-09-19	N.V. Nutricia	Carbohydrates mixture
US8580295B2 (en)	1998-08-11	2013-11-12	N.V. Nutricia	Carbohydrates mixture
US8277836B2 (en)	1998-08-11	2012-10-02	N.V. Nutricia	Carbohydrates mixture
US20100016214A1 (en) *	1998-08-11	2010-01-21	N.V. Nutricia	Carbohydrates mixture
US20060110516A1 (en) *	2002-08-30	2006-05-25	Holtus Maria F	Foaming ingredient and products containing the ingredient
US8557794B2 (en) *	2003-10-24	2013-10-15	N.V. Nutricia	Immunemodulating oligosaccharides
EP1935425A3 (fr) *	2003-10-24	2008-09-03	N.V. Nutricia	Oligosaccharide immunémodulant pour le traitement et/ou la prévention de la bronchopneumopathie chronique obstructive (COPD)
US20070098762A1 (en) *	2003-10-24	2007-05-03	N.V. Nutricia	Immunemodulating oligosaccharides
EP1721612A3 (fr) *	2003-10-24	2007-05-09	N.V. Nutricia	Oligosaccharides immunomodulateurs
EP2305269A3 (fr) *	2003-10-24	2011-07-13	N.V. Nutricia	Oligosaccharides immunomodulateurs
EP1733730A3 (fr) *	2003-10-24	2006-12-27	N.V. Nutricia	Oligosaccharides immunomodulateurs
EP2223691A1 (fr) *	2003-10-24	2010-09-01	N.V. Nutricia	Oligosaccharides immunomodulateurs
AU2004283628B2 (en) *	2003-10-24	2010-07-22	N.V. Nutricia	Immunemodulating oligosaccharides
EP2123282A3 (fr) *	2003-10-24	2010-01-20	N.V. Nutricia	Oligosaccharide immunémodulant
WO2005039597A3 (fr) *	2003-10-24	2005-07-14	Nutricia Nv	Oligosaccharides immunomodulatrices
EP1911453A3 (fr) *	2003-10-24	2008-09-03	N.V. Nutricia	Oligosaccharide immunémodulant
US10426791B2 (en)	2004-05-17	2019-10-01	N.V. Nutricia	Synergism of GOS and polyfructose
US20100069320A1 (en) *	2004-05-17	2010-03-18	N.V. Nutricia	Synergism of gos and polyfructose
US9084433B2 (en)	2004-06-06	2015-07-21	N. V. Nutricia	Intestinal barrier integrity
US10499676B2 (en)	2004-06-06	2019-12-10	N.V. Nutricia	Intestinal barrier integrity
US11076623B2 (en)	2004-06-22	2021-08-03	N.V. Nutricia	Intestinal barrier integrity
US8252769B2 (en)	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
US20080064656A1 (en) *	2004-06-22	2008-03-13	N,V, Nutricia	Improvement of intestinal barrier integrity
US20100167982A1 (en) *	2004-06-22	2010-07-01	N.V. Nutricia	Barrier integrity in hiv patients
EP1629850A1 (fr)	2004-08-24	2006-03-01	Nutricia N.V.	Composition nutritive comprenant des oligosaccharides indigestes
US20070274983A1 (en) *	2004-08-24	2007-11-29	N.V. Nutricia	Nutritional Composition Comprising Immunoglobulins and Oligosaccharides
US9566291B2 (en)	2004-08-24	2017-02-14	N.V. Nutricia	Nutritional composition comprising indigestible oligosaccharides
EP2359858B1 (fr)	2004-08-24	2022-08-10	N.V. Nutricia	Composition nutritive comprenant des oligosaccharide indigestes.
US8277835B2 (en)	2004-08-24	2012-10-02	N. V. Nutricia	Nutritional composition comprising immunoglobulins and oligosaccharides
US20080124323A1 (en) *	2004-08-24	2008-05-29	N.V. Nutricia	Nutritional Composition Comprising Indigestible Oligosaccharides
EP1784222B1 (fr) *	2004-08-24	2018-10-10	N.V. Nutricia	Composition nutritive comprenant des oligosaccharide indigestes.
US20080171720A1 (en) *	2005-04-21	2008-07-17	N.V. Nutricia	Nutritional Supplement For Hiv Patients
US20090082249A1 (en) *	2005-04-21	2009-03-26	N.V. Nutricia	Nutritional supplement for a category of hiv patients
US20110236500A1 (en) *	2005-04-21	2011-09-29	N.V. Nutricia	Nutritional supplement with colostrum and epa or dha or gla
EP1714562A1 (fr) *	2005-04-22	2006-10-25	N.V. Nutricia	Procédé de séchage d'oligosaccahrides d'acide uronique
US8048997B2 (en)	2005-04-22	2011-11-01	N.V. Nutricia	Process for drying uronic acid oligosaccharides
WO2006112718A3 (fr) *	2005-04-22	2007-03-29	Nutricia Nv	Procede de sechage des oligosaccharides de l'acide uronique
US20080193627A1 (en) *	2005-04-22	2008-08-14	N.V. Nutricia	Process For Drying Uronic Acid Oligosaccharides
US8673878B2 (en)	2005-10-06	2014-03-18	Ntnu Technology Transfer As	Mucosal treatment
US20090156549A1 (en) *	2005-10-06	2009-06-18	Ntnu Technology Transfer As	Mucosal treatment
US8754063B2 (en)	2005-10-06	2014-06-17	NTNU Technology Transfers AS	Use of oligouronates for treating mucus hyperviscosity
US20090010914A1 (en) *	2005-10-06	2009-01-08	Ntnu Technology Transfer As	Use of Oligouronates for Treating Mucus Hyperviscosity
GB2430881A (en) *	2005-10-06	2007-04-11	Ntnu Technology Transfer As	Use of an oligoelectrolyte polyol to treat mucosal hyperviscosity
GB2430881B (en) *	2005-10-06	2010-10-13	Ntnu Technology Transfer As	Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
US9107438B2 (en)	2005-10-21	2015-08-18	N.V. Nutricia	Preventing diseases in infants delivered via caesarean section
US9585416B2 (en)	2005-10-21	2017-03-07	N.V. Nutricia	Preventing diseases in infants delivered via caesarean section
US9596876B2 (en)	2005-10-21	2017-03-21	N. V. Nutricia	Method for stimulating the intestinal flora
US20090263537A1 (en) *	2005-10-21	2009-10-22	Joachim Schmitt	Method for stimulating intestinal barrier integrity after non-natural birth
US20090162323A1 (en) *	2005-10-21	2009-06-25	N.V. Nutricia	Method for Stimulating the Intestinal Flora
US8715769B2 (en)	2005-10-21	2014-05-06	N.V. Nutricia	Preventing diseases in infants delivered via caesarean section
WO2007046697A1 (fr) *	2005-10-21	2007-04-26	N.V. Nutricia	Methode pour traiter et/ou pour prevenir des infections chez des bebes venus au monde par cesarienne
WO2007067033A1 (fr) *	2005-12-06	2007-06-14	N.V. Nutricia	Préparation contenant des oligosaccharides pour le traitement prophylactique/thérapeutique d'infections
AU2006323322B2 (en) *	2005-12-06	2012-08-09	N.V. Nutricia	Composition containing oligosaccharides for the treatment / prevention of infections
WO2007067053A1 (fr) *	2005-12-06	2007-06-14	N.V. Nutricia	Préparation contenant des oligosaccharides pour le traitement prophylactique/thérapeutique d'infections
US20090156550A1 (en) *	2005-12-06	2009-06-18	Potappel-Van T Land Belinda	Composition containing oligosaccharides for the treatment/prevention of infections
US20100152122A1 (en) *	2007-04-12	2010-06-17	Ntnu Technology Transfer As	Oligo-guluronate and galacturonate compositions
US8841279B2 (en)	2007-04-12	2014-09-23	Norwegian University Of Science And Technology	Oligo-guluronate and galacturonate compositions
US8680072B2 (en)	2007-11-27	2014-03-25	Algipharma As	Use of alginate oligomers in combating biofilms
US10624920B2 (en)	2007-11-27	2020-04-21	Algipharma As	Use of alginate oligomers in combating biofilms
US9877983B2 (en)	2007-11-27	2018-01-30	Algipharma As	Use of alginate oligomers in combating biofilms
US20100305062A1 (en) *	2007-11-27	2010-12-02	Algipharma Ipr As	Use of alginate oligomers in combating biofilms
US20110021421A1 (en) *	2007-12-05	2011-01-27	N.V. Nutricia	Liquid enteral nutritional composition with a low specific protein volume
US8409651B2 (en)	2007-12-05	2013-04-02	N. V. Nutricia	High energy liquid enteral nutritional composition
US8999423B2 (en)	2007-12-05	2015-04-07	N. V. Nutricia	High energy liquid enteral nutritional composition
US9345256B2 (en)	2007-12-05	2016-05-24	N.V. Nutricia	High energy liquid enteral nutritional composition
US20110008485A1 (en) *	2007-12-05	2011-01-13	N.V. Nutricia	Protein-dense micellar casein-based liquid enteral nutritional composition
US20110038982A1 (en) *	2007-12-05	2011-02-17	N.V. Nutricia	High energy liquid enteral nutritional composition
US20110077189A1 (en) *	2008-02-01	2011-03-31	N.V. Nutricia	Composition for stimulating natural killer cell activity
US9420816B2 (en)	2008-03-12	2016-08-23	N.V. Nutricia	High protein liquid enteral nutritional composition
US8815797B2 (en)	2008-03-12	2014-08-26	N.V. Nutricia	High protein liquid enteral nutritional composition
US20110046048A1 (en) *	2008-03-12	2011-02-24	N.V. Nutricia	High protein liquid enteral nutritional composition
US20110150851A1 (en) *	2008-06-30	2011-06-23	N.V. Nutricia	Nutritional composition for infants delivered via caesarean section
US8987215B2 (en)	2009-03-23	2015-03-24	Ntnu Technology Transfer As	Composition for use in gene therapy
US8529890B2 (en)	2009-03-23	2013-09-10	Ntnu Technology Transfer As	Composition for the administration of polymeric drugs
US9801901B2 (en)	2009-06-03	2017-10-31	Algipharma As	Alginate oligomers for use in overcoming multidrug resistance in bacteria
US9018158B2 (en)	2009-06-03	2015-04-28	Algipharma As	Alginate oligomers for use in overcoming multidrug resistance in bacteria
US8815831B2 (en)	2009-06-03	2014-08-26	Algipharma As	Treatment of Acinetobacter with alginate oligomers and antibiotics

Also Published As

Publication number	Publication date
EP1267891A2 (fr)	2003-01-02
US7759324B2 (en)	2010-07-20
WO2001060378A2 (fr)	2001-08-23
SK288087B6 (sk)	2013-06-03
NO20023846D0 (no)	2002-08-14
US20060105990A1 (en)	2006-05-18
HUP0300409A3 (en)	2003-09-29
EP1267891B1 (fr)	2011-07-27
CA2400244A1 (fr)	2001-08-23
HUP0300409A2 (hu)	2003-06-28
US20070054877A1 (en)	2007-03-08
CA2765218A1 (fr)	2001-08-23
ATE517628T1 (de)	2011-08-15
CN101057853A (zh)	2007-10-24
AU2001246441B2 (en)	2005-12-15
JP4965043B2 (ja)	2012-07-04
ES2370478T3 (es)	2011-12-16
MXPA02007970A (es)	2002-11-29
JP2003522796A (ja)	2003-07-29
RU2002124589A (ru)	2004-03-10
US20110152168A1 (en)	2011-06-23
WO2001060378A3 (fr)	2002-04-18
SK11682002A3 (sk)	2003-03-04
RU2267324C2 (ru)	2006-01-10
ZA200206177B (en)	2003-02-06
PT1267891E (pt)	2011-11-15
BR0108354B1 (pt)	2014-07-08
PL204585B1 (pl)	2010-01-29
TR200202008T2 (tr)	2002-12-23
IL151274A (en)	2012-05-31
CN1404395A (zh)	2003-03-19
US7919479B2 (en)	2011-04-05
NO20111024L (no)	2002-10-11
EP2298325A1 (fr)	2011-03-23
DK1267891T3 (da)	2011-11-14
BR0108354A (pt)	2003-03-11
NO331735B1 (no)	2012-03-12
NO20023846L (no)	2002-10-11
AU4644101A (en)	2001-08-27
CY1111968T1 (el)	2015-11-04
EP2305270A1 (fr)	2011-04-06
NZ520642A (en)	2004-04-30
CZ20022702A3 (cs)	2003-01-15
CA2400244C (fr)	2012-03-27
HK1053986A1 (zh)	2003-11-14
CN101057853B (zh)	2015-04-01
DE10006989A1 (de)	2001-08-23
PL363272A1 (en)	2004-11-15

Publication	Publication Date	Title
US7919479B2 (en)	2011-04-05	Antiadhesive carbohydrates
JP4972606B2 (ja)	2012-07-11	炭水化物混合物

Legal Events

Date	Code	Title	Description
2002-08-14	AS	Assignment	Owner name: N.V. NUTRICIA, NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STAHL, BERND;BOEHM, GUNTHER;REEL/FRAME:013322/0084;SIGNING DATES FROM 20020801 TO 20020805
2006-10-02	STCB	Information on status: application discontinuation	Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

Date

Code

Title

Description

2002-08-14

Assignment

Owner name: N.V. NUTRICIA, NETHERLANDS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:STAHL, BERND;BOEHM, GUNTHER;REEL/FRAME:013322/0084;SIGNING DATES FROM 20020801 TO 20020805

2006-10-02

STCB

Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION